NCT05964855

Brief Summary

In summary, subjects will be asked to wear a number of sensors and use different ankle-foot prostheses in place of their customary prosthesis. Data will be collected from the wearable sensors, VICON motion capture system, video cameras, and force sensors in the ground as they walk on level-ground, on a treadmill, and on stairs. The controller of any powered prosthesis will be electronically adjusted between trials or while the subject walks to determine how their gait changes in response to these changes. Trials will also be conducted with a standard passive prosthesis that would be prescribed for a person of similar height and weight.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 11, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

July 28, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

July 28, 2023

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

January 13, 2025

Status Verified

January 1, 2025

Enrollment Period

2.1 years

First QC Date

July 11, 2023

Last Update Submit

January 9, 2025

Conditions

Keywords

Foot-ankle deviceprosthesismobility

Outcome Measures

Primary Outcomes (3)

  • User device preference for level-ground walking

    Determine which device the users prefer for level-ground walking by gauging user feedback through an evaluation questionnaire. Evaluation units will be a sliding scale ranging from "Very unfavorable" to "Very favorable" with neutral in the middle. Subjects will be asked to rank the 5 interventions from best to worst for the specific task.

    From enrollment to the end of trial (2 sessions, 8 hours total per patient)

  • User device preference for stair ascent & descent

    Determine which device the users prefer for stair ascent \& descent by gauging user feedback through an evaluation questionnaire. Evaluation units will be a sliding scale ranging from "Very unfavorable" to "Very favorable" with neutral in the middle. Subjects will be asked to rank the 5 interventions from best to worst for the specific task.

    From enrollment to the end of trial (2 sessions, 8 hours total per patient)

  • User device preference for sloped ground ascent & descent

    Determine which device the users prefer for 8-degree sloped ground ascent \& descent by gauging user feedback through an evaluation questionnaire. Evaluation units will be a sliding scale ranging from "Very unfavorable" to "Very favorable" with neutral in the middle. Subjects will be asked to rank the 5 interventions from best to worst for the specific task.

    From enrollment to the end of trial (2 sessions, 8 hours total per patient)

Secondary Outcomes (4)

  • Effect of device on level-ground walking gait

    From enrollment to the end of trial (2 sessions, 8 hours total per patient)

  • Effect of device on stair ascent & descent gait

    From enrollment to the end of trial (2 sessions, 8 hours total per patient)

  • Effect of device on sloped ground walking gait

    From enrollment to the end of trial (2 sessions, 8 hours total per patient)

  • Effect of device on ground reaction force during ambulation

    From enrollment to the end of trial (2 sessions, 8 hours total per patient)

Study Arms (1)

Unilateral Subject Group

EXPERIMENTAL

Foot-ankle devices will be given to this group to evaluate and compare the devices.

Device: MIT Variable Stiffness ProsthesisDevice: MIT Variable Equilibrium Angle ProsthesisDevice: MIT Sliding Beam Passive ProsthesisDevice: Ossur Pro-flex XCDevice: Blatchford Elan Variable-Dampening Prosthesis

Interventions

Proprietary electronically-controlled prosthesis that can vary its effective stiffness.

Unilateral Subject Group

Proprietary manually-controlled prosthesis that can vary its effective ankle equilibrium angle.

Unilateral Subject Group

Proprietary fixed-stiffness passive foot-ankle prosthesis.

Unilateral Subject Group

Commercially-available passive fixed-stiffness foot-ankle prosthesis by Ossur.

Unilateral Subject Group

Commercially-available electronically-controlled prosthesis that can vary its effective dampening.

Also known as: Elan
Unilateral Subject Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Person with unilateral transtibial amputation
  • K3 or K4 Medicare mobility rating
  • Ages 18-65

You may not qualify if:

  • Below K3 Medicare mobility rating
  • Outside of age range (liability and safety reasons)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MIT Media Laboratory

Cambridge, Massachusetts, 02139, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 11, 2023

First Posted

July 28, 2023

Study Start

July 28, 2023

Primary Completion

September 1, 2025

Study Completion

December 31, 2025

Last Updated

January 13, 2025

Record last verified: 2025-01

Locations